Rating History for INmune Bio Inc. (INMB) by Lucid Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/11/2026 | Elemer Piros | Upgrade | Buy (Neutral) |
9.00 (N/A) |
1.28 (1.43) |
11.72% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/11/2026 | Elemer Piros | Upgrade | Buy (Neutral) |
9.00 (N/A) |
1.28 (1.43) |
11.72% | Details |
![]() |
|||||||
![]() |
|||||||